Read more
Hochaktuelle Ergebnisse aus der Forschung! Das Immunsystem ist für viele Krankheiten Brennpunkt der Forschung. Auch in der Krebsforschung lassen sich immer mehr, neue und verbesserte Erkenntnisse aus immunologischen Vorgängen ableiten. In diesem Buch findet der Leser alles zu diesem Gebiet, wie z.B. die neuesten Erkenntnisse über die Wirkung von Interleukin.
Recent advances in biotechnology, especially in haematological and immunological research, may have considerable impact on tumour therapy. The actual gap between in vitro research and in vivo studies still asks for somewhat empirically based approaches that may well be guided by the in vitro results. Both aspects are discussed in this volume of the ESO Monographs.
List of contents
Contents: Introduction and Overview.- Lymphopoietic Growth Factors: Pathophysiology of T-Cell Mediated Shock Induced by Bacterial Superantigens.- Natural Killer Cells and Interleukin-2-Activated Killer Cells.- Tumour Immunogenicity Induced by Exogenous Interleukins.- Cytokine Gene Therapy of Cancer.- Analysis of T-Cell Receptor Variability in Tumour Infiltrating Lymphocytes.- Clinical Studies with Interleukin-2: An Overview.- Clinical Trials with Local Administration of Lymphopoietic Growth Factors.- Clinical Trials with Interleukin-2. The Rome Experience. Haematopoietic Growth Factors: Lymphohaematopoietic Growth Factor Use in Lung Cancer Patients.- Clinical Trials with Haematopoietic Growth Factors and Peripheral Blood Stem Cells.
About the author
Prof. Dr. med. Roland Mertelsmann leitet als Ärztlicher Direktor die Abteilung Innere Medizin I, Hämatologie/Onkologie der Medizinischen Universitätsklinik und Poliklinik des Universitätsklinikums Freiburg.
